Vulvovaginal candidiasis: Susceptibility factors of the host and virulence of the yeasts;Candidíase vulvovaginal: Fatores predisponentes do hospedeiro e virulência das leveduras

Jornal Brasileiro de Patologia e Medicina Laboratorial

Volumn 43, Issue 5, 2007, Pages 319-327

  Álvares, Cassiana Aparecida ^a   Svidzinski, Terezinha Inez Estivalet ^b   Consolaro, Márcia Edilaine Lopes ^b  

^a Aperfeiçoamento em Osteopatia em andamento na Escuela de Osteopatia de Madrid   (Brazil)

^b STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

Candida albicans; Susceptibility factors; Virulence factors; Vulvovaginal candidiasis

Indexed keywords

EID: 37349016042     PISSN: 16762444     EISSN: 16784774     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. ALMEIDA FILHO, G.L.; PASSOS, M.R.L.; GOUVÊA, T.V.D. Candidíase. In: PASSOS, M.R.L. Doenças sexualmente transmissíveis. 4 ed. Rio de Janeiro: Cultura Médica, 1995.
2. ASHMAN, R.B.; PAPADIMITRIOU, J.M.. Production and function of cytokines in natural and acquired immunity to Candida albicans infection. Microbiol Rev, v. 59, p. 646-72, 1995.
3. BROOKS, G.F.; BUTEL, J.S.; MORSE, S.A. Jawetz, Melnick & Adelberg Microbiologia Médica. 21 ed. Rio de Janeiro: Guanabara-Koogan, 2000.
4. CALDERONE, R.A.; FONZI, W. Virulence factors of Candida albicans. Trends Microbiol, v. 9, n.7, p. 327-31, 2001.
5. CARDONA-CASTRO, N. et al. Proteinase detection, DNA typing and antimycotic susceptibility of Candida isolates from Colombian women with vulvovaginal candidiasis. Rev Iberoam Micol, v. 19, p. 89-94, 2002.
6. CARVALHO, R.J.V. et al. IgA, IgE e subclasses de IgG anti-Candida albicans no soro e lavado vaginal de pacientes com candidíase vulvovaginal. Rev Assoc Med Bras, v. 49, n. 4, p. 42-30, 2003.
7. CAVALCANTE, V.L.N.; MIRANDA, A.T.; PORTUGAL, G.M.P. Rastreamento de candidose vaginal durante a prevenção do câncer cérvico-uterino. DST - J Bras Doenças Sex Transm, v. 17, n. 1, p. 44-48, 2005.
8. CHAFFIN, W.L. et al. Cell wall and secreted proteins of Candida albicans: identification, function, and expression. Microbiol Molec Biol Rev, v. 62, p. 130-80, 1998.
9. CHONG, P.P. et al. Genetic relatedness of Candida strains isolated from women with vaginal candidiasis in Malaysia. J Med Microbiol, v. 52, p. 657-66, 2003.
10. CONSOLARO, M.E.L. et al. Correlation of Candida species and symptoms among patients with vulvovaginal candidiasis in Maringá, Paraná, Brazil. Rev Iberoam Micol, v. 21, p. 202-05, 2004.
11. CONSOLARO, M.E.L. et al. Vulvovaginal candidiasis is associated with the production of germ tubes by Candida albicans. Mycopathol,v. 159, p. 501-07, 2005.
12. CORSELLO, S. et al. An epidemiological survey of vulvovaginal candidiasis in Italy. Eur J Obstet Gyenecol Reprod Biol, v. 110, p. 66-72, 2003.
13. COTRAN, R.S.; KUMAR, V.; COLLINS, T. Robbins. Patologia estrutural e funcional. 6 ed. Rio de Janeiro: Guanabara-Koogan, 2000.
14. DAN, M.; POCH, F.; LEVIN, D. High rate of vaginal infections caused by non-C. albicans Candida species among asymptomatic women. Med Mycol, v. 40, p. 383-86, 2002.
15. DE BERNANRDIS, F.; SULLIVAN, P.A.; CASSONE, A. Aspartyl proteinases of Candida albicans and their role in patogenicity. Med Mycol, v. 39, p. 303-13, 2001.
16. DOSTÁL, J. et al. Simple method for screening Candida species isolates for the presence of secreted proteinases: a tool for the prediction of successful inhibitory treatment. J Clin Microbiol, v. 41, p. 712-16, 2003.
17. DOUGLAS, L. J. Adhesion of pathogenic Candida species to host surfaces. Microbiol Sci, v. 2, p. 243-47, 1985.
18. DOUGLAS, L.J. Candida biofilms and their role in infection. Trends Microbiol, v. 11, p. 30-36, 2003.
19. FERNANDES, C.E.; MACHADO, R.B. Aspectos etiopatogênicos, diagnósticos e terapêuticos da candidíase vulvovaginal. Rev Bras Med, v. 7, p. 100-4, 1996.
20. FERRAZA, M.H.S.H. et al. Caracterização de leveduras isoladas da vagina e sua associação com candidíase vulvovaginal em duas cidades do sul do Brasil. RBGO, v. 27, n. 2, p. 58-63, 2005.
21. FERRER, J. Vaginal candidosis: epidemiological and etiological factors. Int Journal Gynaecol Obstet, v. 71, p. 21-27, 2000.
22. FIDEL Jr., P.L; SOBEL, J.D. Immunopathogenesis of recurrent vulvovaginal candidiasis. Rev Clin Microbiol, v. 9, p. 335-48, 1996.
23. FINLAY, B.B.; FALKOW, S. Common themes in microbial pathogenicity. Microbiol Rev, v. 53, p. 210-30, 1989.
24. GHANNOUM, M.A.; RADWAN, S.S. Candida adherence to epithelial cells. New York: CRC Press, 1990.
25. GHANNOUM, M.A. Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev, v. 13, p. 122-43, 2000.
26. GOMPEL, C.; KOSS, L.G. Citologia ginecológica e suas bases anatomoclínicas. São Paulo: Manole, 1997.
27. GOSWAMI D, G.R. et al. Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy. Antimicrob Agents Chemother, v. 49, n. 6, p. 2336-42, 2005.
28. HAMMER, K.A.; CARSON, C.F.; RILEY, T.V. Malaleuca alternifolia (tea tree) oil inhibits germ formation by Candida albicans. Med Mycol, v. 38, p. 355-62, 2000.
29. HANN, Y.; MORRISON, R.P.; CUTLER, J.E. A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection. Infect immune, v. 66, p. 5771-76, 1998.
30. HAZEN, K.C.; WU, J.G.; MASUOKA, J. Comparison of hydrophobic properties of Candida albicans and Candida dubliniensis. Infect Immun, v. 69, p. 779-86, 2001.
31. JABRA-RIZKI, M.A. et al. Cell surface hydrophobicity-associated adherence of Candida dubliniensis to human buccal ephitelial cells. Rev Iberoam Micol, v. 18, p. 17-22, 2001.
32. JAYATILAKE, J.A.M.S; SAMARANAYAKE, Y.H.; SAMARANAYAKE, L.P. An ultrastructural and a cytochemical study of candidal invasion of reconstituted human oral epithelium. J Oral Med, v. 34, p. 240-46, 2005.
33. KRAUTGARTNER, V.L. et al. Candida attachment to oral epithelium. Oral Microbiol Immunol, v. 17, p. 60-4, 2002.
34. th ed. Amsterdam: Elsevier, 1998.
35. LACAZ, C.S. Candidíases. São Paulo: Editora da Universidade de São Paulo, 1980.
36. LACAZ, C.S; PORTO, E.; MARTINS, J.E.C. Micologia médica: fungos, actinomicetos e algas de interesse médico. 8 ed. São Paulo: Sarvier, 1991.
37. LO, H. et al. Nonfilamentous Candida albicans mutants are avirulent. Cell, v. 90, p. 939-49, 1997.
38. Mac DONALD, F.; ODDS, F.C. Virulence for mice of a proteinase: secreting strain of Candida albicans and a proteinase-deficient mutant. J Microbiol, v. 129, p. 431, 1983.
39. MARDH, P.A. et al. Facts and myths on recurrent vulvovaginal candidosis: a review on epidemiology, clinical manifestations, diagnosis, pathogenesis and therapy. Int J STD AIDS, v. 13, p. 522-39, 2002.
40. MARRAZZO, J.M. Vulvovaginal candidiasis: over the counter doesn't seem to lead to resistance. BMJ, v. 326, p. 993-94, 2003.
41. MATTHEWS, R.; BURNIE, J. Antifungal antibodies a new approach to the treatment of systemic candidiasis. Curr Opin Investig Drugs, v. 2, p. 472-76, 2001.
42. MATTOS, A.H.S. et al. Prevalência de leveduras do gênero Candida em secreção vaginal. Rev Bras Ginecol Obst, v. 15, n. 4, p. 163-66, 1993.
43. MORAGUES, M.D. et al. A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C albicans activities. Infec Immun, v. 71, p. 5273-79, 2003.
44. NARDIN, M.E. et al. Prevalencia de la candidiasis vulvovaginal y su relación con algunos factores de riesgo. Rev Argent Microbiol, 2000.
45. O'TOOLE, G.A.; KAPLAN, H.B.; KOLTER, R. Biofilm formation as microbiol development. Ann Rev Microbiol, v. 54, p. 49-79, 2000.
46. ODDS, F.C. et al. Candida concentrations in the vagina and their association with signs and symptoms of vaginal candidosis. J Med Vet Mycol, v. 26, p. 277-83, 1988.
47. PATEL, D.A. et al. Risk factors for recurrent vulvovaginal candidiasis in women receiving maintenance antifungal therapy: results of a prospective cohort study. Am J Obst Gyn, v. 190, p. 644-53, 2004.
48. PEREIRA, I.D.B. et al. Vulvovaginites por Candida albicans em pacientes ambulatoriais do Hospital Universitário Betina Ferro de Souza. Rev Bras Anál Clin, v. 28: 53-4, 1996.
49. PFALLER, M.A. Epidemiological typing methods for mycoses. Clin Infect Dis, v. 14, p. 4-10, 1992.
50. PICHOVÁ, I. et al. Secreted aspartic proteinases of Candida albicans, Candida tropicalis, Candida parapsilosis and Candida lusitaniae: inhibition with peptidomimetic inhibitors. Eur J Biochem, v. 268, p. 2669-77, 2001.
51. REED, B.D. et al. Sexual behavior and other risk factors for Candida vulvovaginitis. J Womens Health Gend Based Med, v. 9, p. 645-55, 2000.
52. RIPPON, J.W. Medical micology. The pathogenic fungi and the pathogenic actinomycetes. Philadelphia: Saunders, 1974.
53. ROSA, M.I.; RUMEL, D. Fatores associados à candidíase vulvovaginal: estudo exploratório. Rev Bras Ginecol Obstet, v. 26, n. 1, p. 65-70, 2004.
54. SALVATORE, C.A. Candidíase vulvovaginal. In: LACAZ, C.S. Candidíases. São Paulo: Editora da Universidade de São Paulo, 1980.
55. SCHALLER, M. et al. The secreted aspartyl proteinases Sap 1 and Sap 2 cause tissue damage in an in vitro model of vaginal candidiasis based on reconstituted human vaginal epithelium. Infect Immun, v. 71, p. 3227-34, 2003.
56. SHIN, J.H. et al. Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources. J Clin Microb, v. 40, p. 1244-56, 2002.
57. SOBEL, J.D. Vaginal infections in adult women. Med Clin North Am, v. 74, p. 1575-602, 1990.
58. SOBEL, J.D. Candidal vulvovaginitis. Clin Obstet Gynecol, v. 36, p. 153-12, 1993.
59. SOBEL, J.D. Vulvovaginitis due to Candida glabrata: an emerging problem. Mycoses, v. 41, suppl. 2, p. 18-22, 1998.
60. SOBEL, J.D. et al. Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole. Am J Obstet Gynecol, v. 185, p. 363-9, 2001.
61. SOLL, D.R. Candida commensalism and virulence: the evolution of phenotypic plasticity. Acta Tropica, v. 81, p. 101-10, 2002.
62. SPINILLO, A. et al. Recurrent vaginal candidiasis: results of a cohort study of sexual transmission and intestinal reservoir. J Repro Med, v. 37, p. 343-47, 1992.
63. SULLIVAN, D. et al. Oligonucleotide fingerprinting of isolates of Candida species other than C. albicans and of atypical Candida species from human immunodeficiency virus-positive and AIDS patients. J Clin Microbiol, v. 31, p. 2124-33, 1993.
64. WAIN, W.A.; PRICE, F.M.; CAWSON, R.A. Factors affecting plague formation by Candida albicans infecting chick chorio-allantoic membrane. Sabour, v. 14, p. 149-54, 1976.
65. WHITE, T.C.; MIYASAKI, S.H.; AGABIAN, N. Three distinct secreted aspartyl proteinase in Candida albicans. J Bacteriol, v. 175, p. 6126-33, 1993.
66. WINNER, H. S.; HURLEY, R. Candida albicans. London: Churchill, 1964.
67. WILKINSON, B. M. et al. A new sensate polynucleotide probe for distinguishing Candida albicans strains and its use with a computer-assisted archiving and pattern comparison system. J Med Vet Mycol, v. 30, p. 123-31, 1992.
68. ZIARRUSTA, G.B. Vulvovaginitis candidiásica. Rev Iberoam Micol, v. 19, p. 22-4, 2002.